Global CD25 (IL2R alpha) Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global CD25 (IL2R alpha) Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
CD25 (IL2R alpha) Antibody is an antibody directed against the CD25 protein (interleukin-2 receptor alpha chain) in the human immune system.
CD25 (IL2R alpha) Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD25 (IL2R alpha) Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
CD25 is the α subunit of the IL-2 receptor and is widely expressed on the surface of regulatory T cells (Tregs) and other activated immune cells. The binding of this antibody can interfere with IL-2 signaling and affect cell proliferation, differentiation and immune response, especially the negative regulation of immune response. Therefore, CD25 antibody is used as a potential tool for immunomodulatory therapy aimed at modulating the activity of the immune system for the treatment of autoimmune diseases, organ transplant rejection and other diseases, as well as possible applications in the treatment of certain tumors. This makes CD25 antibodies one of the areas of great interest in immunotherapy research.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD25 (IL2R alpha) Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Bio-Techne
Abeomics Inc.
Abcam
Boster Biological Technology
MyBiosource, Inc.
BioLegend
Abbexa
Merck
Arigo Biolaboratories Corp.
Leinco Technologies
Diagnostic BioSystems
Creative Diagnostics
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD25 (IL2R alpha) Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of CD25 (IL2R alpha) Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the CD25 (IL2R alpha) Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of CD25 (IL2R alpha) Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, CD25 (IL2R alpha) Antibody introduction, etc. CD25 (IL2R alpha) Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of CD25 (IL2R alpha) Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
CD25 (IL2R alpha) Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD25 (IL2R alpha) Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
CD25 is the α subunit of the IL-2 receptor and is widely expressed on the surface of regulatory T cells (Tregs) and other activated immune cells. The binding of this antibody can interfere with IL-2 signaling and affect cell proliferation, differentiation and immune response, especially the negative regulation of immune response. Therefore, CD25 antibody is used as a potential tool for immunomodulatory therapy aimed at modulating the activity of the immune system for the treatment of autoimmune diseases, organ transplant rejection and other diseases, as well as possible applications in the treatment of certain tumors. This makes CD25 antibodies one of the areas of great interest in immunotherapy research.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global CD25 (IL2R alpha) Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sino Biological, Inc.
LifeSpan BioSciences, Inc
Bio-Techne
Abeomics Inc.
Abcam
Boster Biological Technology
MyBiosource, Inc.
BioLegend
Abbexa
Merck
Arigo Biolaboratories Corp.
Leinco Technologies
Diagnostic BioSystems
Creative Diagnostics
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD25 (IL2R alpha) Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of CD25 (IL2R alpha) Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the CD25 (IL2R alpha) Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of CD25 (IL2R alpha) Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, CD25 (IL2R alpha) Antibody introduction, etc. CD25 (IL2R alpha) Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of CD25 (IL2R alpha) Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices